2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients
Kahan, S, Spanik, S, Wagnerova, M, Skacel, T, Planko, B, Fitzthum, E, Lindner, E, Soldatenkova, V, Zielinski, C.C, Brodowicz, T
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article